INT200451

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.09
First Reported 2006
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 4
Disease Relevance 1.28
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (DNLZ)
Anatomy Link Frequency
liver 1
lymphocytes 1
DNLZ (Homo sapiens)
Pain Link Frequency Relevance Heat
depression 16 5.00 Very Low Very Low Very Low
tolerance 10 5.00 Very Low Very Low Very Low
Pain 5 5.00 Very Low Very Low Very Low
cva 5 5.00 Very Low Very Low Very Low
anesthesia 2 5.00 Very Low Very Low Very Low
addiction 2 5.00 Very Low Very Low Very Low
beta blocker 2 5.00 Very Low Very Low Very Low
imagery 2 5.00 Very Low Very Low Very Low
Restless leg syndrome 1 5.00 Very Low Very Low Very Low
drug abuse 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Apoptosis 35 90.04 High High
Obesity 119 88.00 High High
Cancer 30 83.36 Quite High
Stroke 106 82.12 Quite High
Death 8 48.88 Quite Low
Body Weight 23 31.40 Quite Low
Suicidal Behaviour 1 22.72 Low Low
Blister 2 19.72 Low Low
Depression 17 5.00 Very Low Very Low Very Low
Immunization 8 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The LTP and HEP interventions are delivered for 36 sessions over 12 weeks to 16 weeks.
Negative_regulation (delivered) of HEP
1) Confidence 0.09 Published 2007 Journal BMC Neurol Section Body Doc Link PMC2222229 Disease Relevance 0.08 Pain Relevance 0
g/ml at 24 h was found to produce a marked inhibition on the HEp2 and HeLa cell proliferation and this dose did not show any adverse effect on normal human lymphocytes.
Negative_regulation (inhibition) of HEp2 in lymphocytes
2) Confidence 0.08 Published 2006 Journal J Carcinog Section Body Doc Link PMC1705806 Disease Relevance 0.60 Pain Relevance 0
It is possible that that >20 n-3 PUFAs reduce DNL by down-regulating SREBP-1 (sterol regulatory element-binding protein-1) and activating PPAR alpha (peroxisome proliferator-activated receptor alpha) as shown by previous studies [33].
Negative_regulation (reduce) of DNL
3) Confidence 0.00 Published 2010 Journal Nutr Metab (Lond) Section Body Doc Link PMC2825514 Disease Relevance 0.27 Pain Relevance 0
In the present study, the high ALA intake induced a 2-fold reduction of fractional DNL in the liver at d21 with no impact on total plasma TG concentration.
Negative_regulation (reduction) of DNL in liver
4) Confidence 0.00 Published 2010 Journal Nutr Metab (Lond) Section Body Doc Link PMC2825514 Disease Relevance 0.33 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox